Skip to main content

Perianal Warts clinical trials at UCSF
1 in progress, 1 open to new patients

  • Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts

    open to eligible people ages 18 years and up

    Study is a dose escalation study. Fifteen patients will be enrolled in 2 treatment cohorts. Five participants (cohort A) will be treated with 200IU Multikine daily, 5 days/week for 2 weeks, off 2 weeks, then again 5 days/week for 2 weeks. If no serious adverse events are noted in cohort A patients, ten participants will be treated in cohort B. Cohort B participants will be treated the same as cohort A participants except that dose will be increased to 400IU Multikine per day.

    San Francisco, California and other locations